Patents by Inventor Pinglei LIU

Pinglei LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-human MSLN antibody and MSLN-targeting immune effector cell
    Patent number: 11957717
    Abstract: The present invention provides an anti-human MSLN-specific antibody and an MSLN-targeting immune effector cell. Also provided is an MSLN-targeting chimeric antigen receptor modified T-cell prepared using the antibody and a use thereof.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: April 16, 2024
    Assignee: HRAIN BIOTECHNOLOGY CO., LTD.
    Inventors: Fei Huang, Tao Peng, Xuemei Zou, Pinglei Liu, Dachun Liu, Hui Huang
  • ANTI-HUMAN MSLN ANTIBODY AND MSLN-TARGETING IMMUNE EFFECTOR CELL
    Publication number: 20230241104
    Abstract: The present invention provides an anti-human MSLN-specific antibody and an MSLN-targeting immune effector cell. Also provided is an MSLN-targeting chimeric antigen receptor modified T-cell prepared using the antibody and a use thereof.
    Type: Application
    Filed: April 9, 2021
    Publication date: August 3, 2023
    Inventors: Fei HUANG, Tao PENG, Xuemei ZOU, Pinglei LIU, Dachun LIU, Hui HUANG